Rasmus T. Hoeg

Also affiliated with Comprehensive Blood & Cancer Center, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia”.

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025017526

N/A

0.267DataRank · unranked

3 citations

Chenyu Lin, David Nemirovsky, Sean Devlin, Kai Rejeski, Kevin J. Curran +43 more

A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps8072

N/A

0DataRank · unranked

5 citations

Santosha A. Vardhana, Anita Kumar, Mehrdad Abedi, Rasmus T. Hoeg, Elad Sharon +2 more

Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients

Blood Cancer Journal(2021)10.1038/s41408-020-00400-4

N/A

0DataRank · unranked

23 citations

Ann Brunson, Joseph M. Tuscano, Brian A. Jonas, Rasmus T. Hoeg, Ted Wun +2 more

A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.006

N/A

0DataRank · unranked

3 citations

JULIAN R. DAVIS, Brian A. Jonas, Joseph M. Tuscano, Aaron S. Rosenberg, Mehrdad Abedi +1 more

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845

N/A

0DataRank · unranked

2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more

Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility

Ophthalmology Science(2025)10.1016/j.xops.2025.100905

N/A

0DataRank · unranked

0 citations

Jennifer McCormack, Dagmar Salazar, Jacquie King, Marisa Salvador, Gerhard Bauer +10 more

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center

Leukemia Research(2022)10.1016/j.leukres.2022.106885

N/A

0DataRank · unranked

8 citations

Benjamin Moskoff, Gwendolyn Ho, Matthew E. Tenold, Tali Azenkot, Margaret L. Krackeler +12 more